| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
4.01 0.02 (0.01%) |
09-18 16:00 |
|
Open: |
4 |
Pre close: |
3.99 |
Target:
|
5.47 
|
|
High: |
4.045 |
Low: |
3.89 |
Resistance:
|
4.68
5.47
|
|
Volume: |
9,676,217 |
Market Cap: |
708M |
Support:
|
3.83
3.31
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.00
|
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
3.91  |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
4.45 |
Stochastic Oscillator |
%K(14,3):
|
57.63 |
|
MA(250): |
3.38 |
%D(3): |
57.82 |
|
Average Volume(K) |
3-Month: |
667894
|
52-Week |
High:
|
6.29 |
|
10-Days: |
525218 |
Low: |
1.38 |
|
RSI |
RSI(14):
|
49.68 |
Change(%): |
24.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.835 |
Return on Equity (ttm) |
-345.9 |
Shares Out. (M) |
176.57 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-43.3 |
Shares Float (M) |
161.13 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.95 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
98.3 |
% Held by Institutions |
90.20 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
-0.353 |
Shares Short (K) |
33560 |
|
Book Value (p.s.) |
0.430 |
EBITDA (p.s.) |
-0.645 |
P/E |
-4.80 |
|
Sales Per Share |
0.279 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.33 |
|
Profit Margin |
-236.65 |
Operating Cash Flow
(M) |
-92.41 |
P/S |
14.39 |
|
Operating Margin |
-233.15 |
Levered Free Cash Flow
(M) |
-52.33 |
P/CF |
-7.66 |
|
|
|
|
|
|
